SAN CARLOS, Calif., Jan. 30, 2018 /PRNewswire-iReach/ -- Protein Metrics Inc., a leading provider of mass spectrometry
Dr. English joins the company from Pfizer, where she successfully characterized biotherapeutic molecules, including monoclonal antibodies (mAb), antibody drug conjugates (ADC), recombinant proteins, and vaccines.
"We are thrilled that such an accomplished scientist has joined our team to help our customers solve problems with their most challenging tasks," says Eric Carlson, Ph.D., President and CEO. "Michelle is also specialized in the analysis of low level proteoforms such as sequence variants and host cell proteins and has developed many methods to simplify and streamline their identification."
Dr. English has also developed reverse-phase, size exclusion (SEC) and hydrophilic interaction chromatography (HILIC) assays to analyze difficult molecules.
She has published in leading peer-review journals such as Journal for the Society of Mass Spectrometry, and Cellular and Molecular Proteomics, and has presented talks at leading conferences.
Dr. English received her Ph.D. in Chemistry from Professor Donald Hunt at the University of Virginia. She also holds an M.B.A. in Finance from the University of Colorado, and a B.S. in Management Science/Business Information Technology from Virginia Technical University.
About Protein Metrics Inc.
Protein analysis should never be limited by software. With a clear focus on protein characterization, Protein Metrics' vendor-neutral software allows scientists to use data generated on analytical instruments like mass spectrometers to quickly identify and report protein sequences as well as any variations from the expected form. We innovate so that biopharmaceutical companies and university research labs can achieve confident results from their analysis and reporting. With our customers, we are boldly advancing protein characterization. Protein Metrics is headquartered in San Carlos, CA at the crossroads of computing and biotechnology in the San Francisco Bay Area. For more information, visit www.proteinmetrics.com.
Media Contact: Joann Calve, Protein Metrics Inc., 339-223-6402, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Protein Metrics Inc.
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All